Skip to main content
HLS Therapeutics Inc. logo

HLS Therapeutics Inc. — Investor Relations & Filings

Ticker · HLS ISIN · US40390B3078 LEI · 549300QKXFY1J71L2D68 TSX Wholesale and retail trade
Open in API
Filings indexed 364 across all filing types
Latest filing 2020-05-07 Regulatory Filings
Country CA Canada
Listing TSX HLS

About HLS Therapeutics Inc.

https://hlstherapeutics.com/

HLS Therapeutics Inc. is a specialty pharmaceutical company focused on the acquisition and commercialization of branded medicines across North America. The company targets products that address unmet needs, primarily in the treatment of psychiatric disorders and cardiovascular disease/risk reduction. Its commercial-stage portfolio includes CLOZARIL® (clozapine) for psychiatric disorders and VASCEPA® (icosapent ethyl) for cardiovascular risk reduction. HLS also commercializes NILEMDO® (bempedoic acid) and NEXLIZET® (bempedoic acid/ezetimibe combination) for the reduction of LDL-cholesterol in patients at risk of cardiovascular disease. HLS ensures reliable market access to these essential therapies by sourcing products directly from originators and best-in-class manufacturing partners.

Recent filings

Filing Released Lang Actions
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F2 Certification of Interim Filings by the CEO of HLS Therapeutics Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended March 31, 2020. The document is primarily an officer certification letter confirming the accuracy and completeness of the interim filings, without containing actual financial data or substantive financial analysis itself. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR) itself. The document length is 3356 characters, which is relatively short and consistent with a certification letter rather than a full interim report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-05-07 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F2 Certification of Interim Filings by the CFO, certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended March 31, 2020. It is primarily an officer certification letter confirming the accuracy and controls related to the interim filings, without containing actual financial statements or substantive financial data itself. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR) itself.
2020-05-07 English
Interim MD&A - English.pdf
Regulatory Filings
2020-05-07 English
News release - English.pdf
Regulatory Filings
2020-04-30 English
Notice of the meeting and record date - English.pdf
AGM Information Classification · 95% confidence The document is a short notice from Computershare to Canadian Securities Regulatory Authorities regarding the upcoming Annual General Meeting (AGM) of HLS Therapeutics Inc. It provides details such as meeting type, record dates, meeting date, location, and proxy material delivery information. The document does not contain any financial data, management discussion, voting results, or detailed report content. It is essentially an announcement about the AGM logistics and proxy material handling. Given the short length (1086 characters) and the nature of the content, this fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related notices about the AGM.
2020-04-17 English
News release - English.pdf
Regulatory Filings
2020-03-31 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.